HUNTER TAUBMAN FISCHER & LI LLC

  • New York
  • Washington D.C.
  • Miami
Picture: Someone typing on a computer

The law firm of Hunter Taubman Fischer & Li LLC

is committed to providing superior service while adhering to the highest ethical standards.

We possess a broad base of knowledge and extensive experience – which provides a distinct advantage to our clients. The firm carefully selects its attorneys from among the top professionals in the legal field.

Our team is committed to achieving professional excellence and providing exceptional service.

homepage_clients homepage_global homepage_growth

The firm offers services specifically designed to enable businesses to grow successfully & consistently. We primarily represent small to medium sized companies focused on increasing revenue and maintaining growth.

Clients in a variety of industries and across all stages of development benefit from the sophisticated legal solutions and astute business acumen provided by the attorneys at the firm.

From routine business decisions to the most complex and global business transactions, our clients rely on us to guide them through their legal needs.

Updates

News

Guidelines for Public Companies during the Federal Government Shutdown

2019-01-13

In light of the federal government shutdown commencing on December 22, 2018, the U.S. Securities and Exchange Commission (“SEC”) remains leanly staffed. This has caused delay in staff’s review of registration statements and other filings, and the SEC will not be able to declare any registration statements effective during the shutdown. Nevertheless, regardless of the SEC’s operational status, EDGAR will still accept filings.

View Article

News

First Nasdaq IPO of 2019: Boustead Client China SXT Pharma Up 43% in SXTC’s Debut After USD$10.2 Million Funding

2019-01-09

HTFL’s Client China SXT Pharmaceuticals, Inc. (the "Company") (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces ("TCMPs"), announced the final closing of its initial public offering on January 3, 2019. Together with the first closing on December 31, 2018, the Company raised approximately $10.2 million in gross proceeds, before deducting underwriting discounts, commissions and other offering expenses, by issuing 2,546,275 ordinary shares at a public offering price of $4.00 per share. 

View Article

Events

2018 EB-5 Convention Los Angeles - Luciana Zamith Fischer Invited as a Panelist

2018-07-20

EB5 Investors Magazine is pleased to present the 2018 Los Angeles EB-5 Convention at The Westin Bonaventure Hotel and Suites on July 23-24, 2018.

This two-day educational, networking event will host a gathering of broker-dealers, developers, immigration and securities attorneys, migration agents, regional centers and other EB-5 program stakeholders.

The event will also feature special guest speakers and sponsorship opportunities.

View Event